Page 2 - Sujalm Patel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zacks Investment Research upgraded shares of Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) from a sell rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus […] ....

Sujalm Patel , Morgan Stanley , Nautilus Biotechnology Inc , Geode Capital Management , Arya Sciences Acquisition Corp , Securities Exchange Commission , Clarius Group , Zacks Investment Research , Marshall Wace , Nautilus Biotechnology Company Profile Get Rating , Cubist Systematic Strategies , Millennium Management , Nautilus Biotechnology , Get Rating , Biotechnology Inc , Exchange Commission , Capital Management , Systematic Strategies , Biotechnology Company Profile , Nautilus Proteomic Analysis Platform , Nasdaq Naut ,